ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Perinatal Psychiatry
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1614577
This article is part of the Research TopicPerinatal mental health: Depression, Anxiety, Stress, and FearView all 24 articles
Antidepressants and hypertensive disorders in pregnancy: a retrospective cohort analysis
Provisionally accepted- 1Monash University, Melbourne, Australia
- 2Monash Addiction Research Centre, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Victoria, Australia
- 3Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia
- 4Powerstats, North Ryde, Australia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: This study investigated relationships between antidepressant use in pregnancy and hypertensive disorders of pregnancy. Design/Setting/Sample: Observational cohort study examining 75,308 births. Methods: Logistic regression analysis. The antidepressant treatment cohort was compared with two groups: all births at this hospital within this time period, and a depressed/anxious cohort not treated with antidepressants in pregnancy. Main Outcome Measures: diagnoses of hypertension, pre-eclampsia or eclampsia, treatment with antihypertensive medication. Results: A statistically significant relationship (p=0.001) between antidepressant use in pregnancy and clinically diagnosed hypertension, OR 2.65, CI 1.45-4.81, when compared with the overall birthing cohort. When covariates were added, including BMI, age and gestational diabetes, this relationship lost statistical significance. The relationship was also non-significant when a depressed/anxious cohort was used as the comparator group: OR 1.49 (p = 0.24, CI 0.77 – 2.88). A highly statistically significant relationship was found between antenatal antidepressant use and pre-eclampsia, OR 2.90, (p < 0.0005, CI 2.1 – 4.0), which retained significance when covariates were added to the regression analysis (OR 2.07, CI 1.45-2.97, p<0.0005). BMI and gestational diabetes were also significant risk factors for pre-eclampsia in this sample. As in other research, depression was also found to be related to pre-eclampsia at a borderline significant level (p=0.086). . When women taking antidepressants were compared with depressed/anxious peers a similarly significant relationship between antidepressant use and hypertension of pregnancy was found: OR 2.56, (p < 0.0005, CI 1.7 – 3.7). We found a highly significant relationship between antidepressant use and eclampsia, OR 2.84 (p < 0.0005, CI 2.06 – 3.92), unchanged when compared with the depressed/anxious cohort: OR 2.84 (p < 0.0005, CI 2.06 – 3.92). Conclusions: This study supports existing research suggesting a strong relationship between antidepressant use in pregnancy and hypertensive disorders. Comparison with a depressed/anxious cohort reduces the risk that these underlying conditions could contribute to this finding.
Keywords: essential hypertension, Hypertension of pregnancy, Pre-Eclampsia, Eclampsia, Depression, Anxiety, Perinatal depression, antidepressant
Received: 19 Apr 2025; Accepted: 07 Oct 2025.
Copyright: © 2025 Breadon, Arunogiri, Turbić, Lavale, Maldonado and Kulkarni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Carolyn Breadon, carolyn.breadon@monash.edu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.